TOMI's SteraMist Sees Surge in Adoption Amid Global Biosecurity Threats
Event summary
- TOMI reports accelerating adoption of SteraMist® platform due to Ebola outbreaks and global biosecurity threats.
- Healthcare providers, emergency response agencies, and transportation operators are increasing investments in advanced infection prevention capabilities.
- Recent outbreaks of Ebola, measles, norovirus, and other highly contagious pathogens have highlighted the need for long-term biosecurity infrastructure.
- TOMI has expanded deployments with healthcare providers, emergency response teams, and specialized pathogen programs internationally and in the U.S.
The big picture
TOMI's growth in SteraMist adoption reflects a broader industry shift towards proactive biosecurity measures. The increasing frequency of pathogen outbreaks is driving long-term investments in advanced decontamination technologies, positioning TOMI as a key player in the global infection prevention market.
What we're watching
- Market Expansion
- How TOMI's expansion into automation, robotics, and autonomous delivery systems will affect large-scale decontamination capabilities.
- Regulatory Compliance
- Whether stricter regulatory requirements will sustain the growing focus on biosecurity preparedness.
- Technological Advancements
- The pace at which emerging technologies will enhance the scalability and efficiency of environmental disinfection solutions.
Related topics